AAV8-RK-RetGC

N/A

Report date: 2025/03/14 15:13:29

Base Information

Drug NameAAV8-RK-RetGC
Drug Alias NameAAV8-RK-RetGC
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceGuanylate cyclase modulators
TargetsGuanylate cyclase
Therapy Area/IndicationsLeber Congenital Amaurosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesMeiragtx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiragtx Ltd
Inactive CompaniesN/A
Active IndicationsLeber Congenital Amaurosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A